Peregrine Pharmaceuticals Company Profile (NASDAQ:PPHM)

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals logoPeregrine Pharmaceuticals, Inc. (Peregrine) is a biopharmaceutical company. The Company operates through two segments: Peregrine, which is engaged in the research and development of monoclonal antibodies for the treatment of cancer, and Avid, which is engaged in providing contract manufacturing services for third party customers on a fee-for-service basis while also supporting its internal drug development efforts. Bavituximab is its lead immunotherapy candidate. Bavituximab is a monoclonal antibody that targets and binds to phosphatidylserine (PS), a immunosuppressive molecule that is usually located inside the membrane of healthy cells, but then flips and becomes exposed on the outside of cells in the tumor microenvironment, causing the tumor to evade immune detection. The Company's subsidiary is Avid Bioservices, Inc. (Avid). Avid provides integrated current good manufacturing practices (cGMP) services from cell line development to commercial biomanufacturing.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: PPHM
  • CUSIP:
Key Metrics:
  • Previous Close: $0.36
  • 50 Day Moving Average: $0.375
  • 200 Day Moving Average: $0.443
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -3.26
  • P/E Growth: 0.000
  • Market Cap: $86.68M
  • Outstanding Shares: 241,456,000
  • Beta: 1.26
Additional Links:
Companies Related to Peregrine Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Peregrine Pharmaceuticals (NASDAQ:PPHM) (?)
Ratings Breakdown: 1 Hold Rating, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $1.00 (178.55% upside)

Analysts' Ratings History for Peregrine Pharmaceuticals (NASDAQ:PPHM)
Show:
DateFirmActionRatingPrice TargetDetails
7/18/2016Noble FinancialReiterated RatingBuy$1.50View Rating Details
7/17/2016FBR & CoReiterated RatingOutperform$1.00View Rating Details
7/15/2016Roth CapitalReiterated RatingHold$0.50View Rating Details
6/1/2015MLV & Co.Reiterated RatingBuy$3.50View Rating Details
(Data available from 8/28/2014 forward)

Earnings

Earnings History for Peregrine Pharmaceuticals (NASDAQ:PPHM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
9/7/2016        
7/14/2016Q416($0.03)($0.05)$18.78 millionViewListenView Earnings Details
3/9/2016Q316($0.07)($0.08)$7.96 million$6.71 millionViewListenView Earnings Details
12/10/2015Q216($0.09)($0.07)$9.52 millionViewListenView Earnings Details
9/9/2015Q116($0.08)($0.08)$9.67 millionViewN/AView Earnings Details
7/14/2015Q315($0.08)($0.07)$6.42 million$9.31 millionViewListenView Earnings Details
3/12/2015Q215($0.08)($0.08)$4.20 million$5.68 millionViewN/AView Earnings Details
12/10/2014Q115($0.07)($0.07)$5.82 million$6.30 millionViewN/AView Earnings Details
9/9/2014Q1($0.06)($0.08)$5.76 million$5.50 millionViewListenView Earnings Details
7/14/2014Q414($0.07)($0.06)$4.75 million$6.47 millionViewN/AView Earnings Details
3/7/2014Q314($0.06)($0.06)$5.09 million$3.90 millionViewN/AView Earnings Details
12/10/2013Q2($0.05)($0.05)$5.74 million$7.35 millionViewListenView Earnings Details
9/9/2013Q1 2014($0.05)($0.05)$4.75 million$4.69 millionViewN/AView Earnings Details
7/11/2013Q4 2013($0.06)($0.06)$3.57 million$4.25 millionViewN/AView Earnings Details
3/12/2013Q3 2013($0.07)($0.04)$3.90 million$7.04 millionViewN/AView Earnings Details
12/10/2012-0.08($0.09)($0.08)$4.03 million$4.03 millionViewN/AView Earnings Details
9/10/2012Q113($0.11)($0.07)$3.97 million$4.25 millionViewN/AView Earnings Details
7/16/2012($0.13)($0.10)ViewN/AView Earnings Details
3/9/2012($0.13)($0.13)ViewN/AView Earnings Details
12/12/2011($0.13)($0.16)ViewN/AView Earnings Details
9/9/2011($0.14)($0.11)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Peregrine Pharmaceuticals (NASDAQ:PPHM)
Current Year EPS Consensus Estimate: $-0.150 EPS
Next Year EPS Consensus Estimate: $-0.110 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20161($0.05)($0.05)($0.05)
Q4 20161($0.05)($0.05)($0.05)
Q1 20172($0.05)($0.03)($0.04)
Q2 20171($0.04)($0.04)($0.04)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Peregrine Pharmaceuticals (NASDAQ:PPHM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Peregrine Pharmaceuticals (NASDAQ:PPHM)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Peregrine Pharmaceuticals (NASDAQ:PPHM)
DateHeadline
News IconHow These Biotech Stocks are Faring? -- Progenics Pharma, Peregrine Pharma, Agios Pharma, and Cara Therapeutics (NASDAQ:PPHM)
www.biomedreports.com - August 26 at 6:38 PM
4-traders.com logoCara Therapeutics : How These Biotech Stocks are Faring? -- Progenics Pharma, Peregrine Pharma, Agios Pharma, and Cara Therapeutics (NASDAQ:PPHM)
www.4-traders.com - August 26 at 9:50 AM
News IconHow is the Crowd Rating Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM)? - Post News (NASDAQ:PPHM)
www.kentuckypostnews.com - August 24 at 9:56 AM
investornewswire.com logoPeregrine Pharmaceuticals Inc. (NASDAQ:PPHM) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:PPHM)
www.investornewswire.com - August 23 at 7:00 PM
capitalcube.com logoETF’s with exposure to Peregrine Pharmaceuticals, Inc. : August 18, 2016 (NASDAQ:PPHM)
www.capitalcube.com - August 18 at 7:04 PM
News IconCrowd Sentiment & Analyst Review on Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) - Post News (NASDAQ:PPHM)
www.kentuckypostnews.com - August 17 at 9:55 AM
stocksdaily.net logoPeregrine Pharmaceuticals Inc. (NASDAQ:PPHM) Ratings in Focus - Stocks Daily (NASDAQ:PPHM)
www.stocksdaily.net - August 16 at 10:09 AM
investornewswire.com logoWill Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) Hit $1.5 Price Target? - Investor Newswire (NASDAQ:PPHM)
www.investornewswire.com - August 16 at 10:09 AM
realistinvestor.com logoAnalysts See Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) Reporting EPS Of $-0.02 - RealistInvestor.com (NASDAQ:PPHM)
www.realistinvestor.com - August 16 at 10:09 AM
News IconTop Earnings to Watch for: Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) - The Voice Registrar (NASDAQ:PPHM)
voiceregistrar.com - August 9 at 7:10 PM
News IconPeregrine Pharmaceuticals Inc (NASDAQ:PPHM) Poised For A Comeback - Street Register (NASDAQ:PPHM)
streetregister.com - August 9 at 7:10 PM
4-traders.com logoPeregrine Pharmaceuticals : Avid Bioservices to Participate in Cambridge Healthtech Institute's (CHI) 8th Annual The Bioprocessing Summit (NASDAQ:PPHM)
www.4-traders.com - August 9 at 10:07 AM
News IconPeregrine Pharmaceuticals Inc (NASDAQ:PPHM) Poised For A Comeback (NASDAQ:PPHM)
streetregister.com - August 9 at 10:07 AM
finance.yahoo.com logoAvid Bioservices to Participate in Cambridge Healthtech Institute’s (CHI) 8th Annual The Bioprocessing Summit (NASDAQ:PPHM)
finance.yahoo.com - August 9 at 10:07 AM
publicnow.com logoAvid Bioservices to Participate in Cambridge Healthtech Institute's (CHI) 8th Annual The Bioprocessing Summit (NASDAQ:PPHM)
www.publicnow.com - August 9 at 10:07 AM
equities.com logoPeregrine Pharmaceuticals Inc. (PPHM) Jumps 5.08% on August 04 - Equities.com (NASDAQ:PPHM)
www.equities.com - August 5 at 7:07 PM
seekingalpha.com logoPeregrine Pharmaceuticals: Top 10 Reasons To Consider A 11.9% Yield From This Debt-Free Company - Seeking Alpha (NASDAQ:PPHM)
seekingalpha.com - July 31 at 10:53 AM
capitalcube.com logoETF’s with exposure to Peregrine Pharmaceuticals, Inc. : July 29, 2016 (NASDAQ:PPHM)
www.capitalcube.com - July 29 at 1:47 PM
tradecalls.org logoPeregrine Pharmaceuticals (PPHM) Shares are Down -1.09% - Trade Calls (NASDAQ:PPHM)
www.tradecalls.org - July 25 at 7:04 PM
News IconEquity Roundup: Stock Performance Focus on Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) - Press Telegraph (NASDAQ:PPHM)
presstelegraph.com - July 22 at 9:51 AM
capitalcube.com logoPeregrine Pharmaceuticals, Inc. :PPHM-US: Earnings Analysis: 2016 By the Numbers : July 22, 2016 (NASDAQ:PPHM)
www.capitalcube.com - July 22 at 9:24 AM
finance.yahoo.com logoPEREGRINE PHARMACEUTICALS INC Financials (NASDAQ:PPHM)
finance.yahoo.com - July 20 at 1:04 PM
streetupdates.com logoOverview of Analysts Suggestions: CytRx Corporation (NASDAQ:CYTR) , Peregrine Pharmaceuticals Inc. (NASDAQ ... - Street Updates (NASDAQ:PPHM)
www.streetupdates.com - July 20 at 9:44 AM
investornewswire.com logoIs $1.5 Price Target Attainable For Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM)? - Investor Newswire (NASDAQ:PPHM)
www.investornewswire.com - July 19 at 6:00 AM
News IconTime To Put On The Watch List? - Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM), EPIRUS Biopharmaceuticals, Inc ... - The Voice Registrar (NASDAQ:PPHM)
voiceregistrar.com - July 19 at 6:00 AM
capitalcube.com logoETF’s with exposure to Peregrine Pharmaceuticals, Inc. : July 18, 2016 (NASDAQ:PPHM)
www.capitalcube.com - July 18 at 2:12 PM
News IconAnalyst Recommended Stock: Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) - News Oracle (NASDAQ:PPHM)
www.newsoracle.com - July 18 at 12:22 PM
finance.yahoo.com logoEdited Transcript of PPHM earnings conference call or presentation 14-Jul-16 8:30pm GMT (NASDAQ:PPHM)
finance.yahoo.com - July 15 at 1:27 PM
streetupdates.com logoAnalyst Rating Fluctuations to Observe: Express Scripts Holding Company (NASDAQ:ESRX) , Peregrine ... - Street Updates (NASDAQ:PPHM)
www.streetupdates.com - July 15 at 12:03 PM
News IconAnalyst Target and Average Rating Watch: Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) - Press Telegraph (NASDAQ:PPHM)
presstelegraph.com - July 15 at 12:03 PM
News IconPeregrine Pharmaceuticals Inc. (NASDAQ:PPHM) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:PPHM)
www.engelwooddaily.com - July 15 at 12:03 PM
News IconMix Wondering Stocks- Tesla Motors (NASDAQ:TSLA), Peregrine Pharmaceuticals (NASDAQ:PPHM), Amazon.com ... - Seneca Globe (NASDAQ:PPHM)
www.senecaglobe.com - July 15 at 12:03 PM
News IconFrontline Trades in Focus- Peregrine Pharmaceuticals (NASDAQ:PPHM), Inovio Pharmaceuticals (NASDAQ:INO ... - Seneca Globe (NASDAQ:PPHM)
www.senecaglobe.com - July 15 at 12:03 PM
equities.com logoPeregrine Pharmaceuticals Inc. (PPHM) Drops 5.58% on July 13 - Equities.com (NASDAQ:PPHM)
www.equities.com - July 15 at 12:03 PM
news.cmlviz.com logoPeregrine Pharmaceuticals Inc Stock Momentum at Critical Inflection Point - CML News (NASDAQ:PPHM)
news.cmlviz.com - July 15 at 12:03 PM
equities.com logoPeregrine Pharmaceuticals Inc. (PPHM) Jumps 11.57% on July 14 - Equities.com (NASDAQ:PPHM)
www.equities.com - July 15 at 12:03 PM
publicnow.com logoPeregrine Pharmaceuticals Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2016 and Recent Developments (NASDAQ:PPHM)
www.publicnow.com - July 14 at 4:48 PM
biz.yahoo.com logoPEREGRINE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclo (NASDAQ:PPHM)
biz.yahoo.com - July 14 at 4:39 PM
publicnow.com logoPeregrine Licenses Novel Exosome-Based Cancer Detection and Monitoring Technology from UT Southwestern Medical Center (NASDAQ:PPHM)
www.publicnow.com - July 14 at 8:38 AM
News IconPeregrine Pharmaceuticals Inc. (NASDAQ:PPHM) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:PPHM)
telanaganapress.com - July 13 at 9:50 AM
investornewswire.com logoStrong Sell Calls For Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) At 0 - Investor Newswire (NASDAQ:PPHM)
www.investornewswire.com - July 13 at 9:50 AM
News IconDo Institutional Investors Love Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)? - Press Telegraph (NASDAQ:PPHM)
presstelegraph.com - July 13 at 9:50 AM
News IconCompany Stock Focus for Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM): Which Way Will Shares Head? - Press Telegraph (NASDAQ:PPHM)
presstelegraph.com - July 8 at 6:56 PM
publicnow.com logoPeregrine to Report Financial Results for the Quarter and Fiscal Year Ended April 30, 2016 After Market Close on July 14, 2016 (NASDAQ:PPHM)
www.publicnow.com - July 7 at 4:31 PM
fiscalstandard.com logoPeregrine Pharmaceuticals Inc. (PPHM) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:PPHM)
www.fiscalstandard.com - July 6 at 11:34 AM
equities.com logoPeregrine Pharmaceuticals Inc. (PPHM) Jumps 9.61% on July 04 - Equities.com (NASDAQ:PPHM)
www.equities.com - July 6 at 11:34 AM
News IconShare Performance Recap for: Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) - Press Telegraph (NASDAQ:PPHM)
presstelegraph.com - July 5 at 6:39 PM
News IconPeregrine Pharmaceuticals Inc. (NASDAQ:PPHM) Company Rating and Target Watch - Telanagana Press (NASDAQ:PPHM)
telanaganapress.com - June 28 at 6:50 PM
News IconNotable Stock's Buzzers: Whiting Petroleum Corp (NYSE:WLL), Peregrine Pharmaceuticals (NASDAQ:PPHM) - NYSE Journal (press release) (NASDAQ:PPHM)
stockznews.com - June 27 at 6:54 PM
investornewswire.com logoStrong Sell Calls Recommendations For Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) At 0 - Investor Newswire (NASDAQ:PPHM)
www.investornewswire.com - June 27 at 6:54 PM

Social

Peregrine Pharmaceuticals (NASDAQ:PPHM) Chart for Sunday, August, 28, 2016


Last Updated on 8/28/2016 by MarketBeat.com Staff